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Introduction
Stiles et al, 1 recently published a study titled “Par-
oxysmal Lone Atrial fibrillation is associated with
an abnormal atrial substrate: Characterizing the 
Second Factor” in The Journal of The American 
College of Cardiology.” Authors demonstrated 
structural and electrophysiological abnormalities 
in the atria of patients with paroxysmal lone atrial 
fibrillation (AF). The authors postulate that these 
factors are likely contributors to the “second fac-
tor” that predisposes to the development and pro-
gression of AF.
AF is the commonest arrhythmia encountered in 
clinical practice. It is associated with a poor clinical
outcome and a high healthcare cost. It is classified
as paroxysmal, persistent or permanent AF. Al-
though each clinical class is distinct, a majority of 
patients with paroxysmal AF ultimately may suffer
from the persistent or permanent AF due to lack 
of appropriate therapy and continued remodeling
of the atria. Lone AF has been defined as AF in an
individual less than 60 years of age with no classic
cardiac risk factors. 2 Although lone AF is associ-
ated with a low incidence of morbidity, the natural
history is that of a progressive increase in incidence
and duration of episodes of AF, with many becom-
ing permanent .3 Present therapeutic approaches
to AF have major limitations, including limited 
efficacy and significant adverse effect liability. Al-
though, in the recent years, AF ablation has been 
shown to have a substantially improved success 
rate over antiarrhythmic drug, 4-7 it has not been 
completely successful, and has been associated 
with adverse events. The realization of AF pro-
gression in otherwise healthy subjects, coupled 
with the limitations of therapy mandate research-
ers to improve the understanding of the mecha-
nisms underlying AF, with the premise that bet-
ter mechanistic insights will lead to innovative 
and innovative therapeutic approaches. As such, 
there has been a wealth of research attempting 
to elucidate the causes of the onset of AF and its 
progression.
In the study by Stiles et al, 1 the authors electro-
physiologically characterized the atrial substrate
of 25 highly symptomatic patients with docu-
mented paroxysmal lone AF, who were under-
going first-time ablation for AF. They compared 
these patients with a reference group of 25 pa-
tients with no history of AF, who had atrioven-
tricular re-entry tachycardia, and were undergo-
ing ablation of a left-sided pathway. All of the 
patients had structurally normal hearts and no 
known risk factors for cardiac disease. In an at-
tempt to isolate the chronic, underlying abnor-
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mality from any acute electrophysiologic effects 
of AF, only patients with no AF documented on 
continuous monitoring for the week prior to the 
study were enrolled. During electrophysiologic 
study, four catheters were positioned in the atria
of these patients, including a coronary sinus cath-
eter, a 10-pole “crista” catheter, a 20-pole catheter
along the lateral right atrium, and a 10-pole rov-
ing catheter positioned at sites in the left atrium 
via a sheath across the atrial septum. Effective re-
fractory period (ERP), conduction velocity (CV), 
and site-specific conduction abnormalities along 
the crista terminals were measured. Electroana-
tomical mapping was conducted, with creation of 
voltage and activation maps of the atria. The pro-
portion of fractionated electrograms, including 
fractionated signals and double potentials, were 
recorded as well. There are two major findings of 
this study as discussed below:
1.Structural Remodeling and Electrophysi-
ological Properties of the Atria in Lone AF
The study demonstrated that when compared 
with reference group, lone AF is associated with 
significant structural abnormalities characterized 
by atrial dilation and loss of endocardial voltage. 
The patients with AF had significantly larger left 
atrial size at baseline than the reference group (41 
± 7 mm vs. 34 ± 4 mm P<0.001). The left and right 
atrial volumes were enlarged by 27% and 36%, re-
spectively. There were lower mean atrial voltage 
(right atrial and left atrial voltages were lowered 
by 41% and 48%) in lone AF patients, suggesting 
the loss of atrial myocardium.
Lone AF is associated with significant P-wave 
prolongation by 35%, atrial refractoriness length-
ening by 10%, intra-atrial conduction decrease 
between 21% and 45%, and a significantly higher 
proportion of fractionated and complex electro-
grams, when compared to the reference group. 
The mean ERP of the patients with AF was sig-
nificantly increased over the reference patients (at 
600 ms: 255 ± 25 ms vs. 222 ± 16 ms, p<0.001; at 
450 ms: 234 ± 20 ms vs. 212 ± 14 ms, p=0.004) with 
no significant difference in the heterogeneity of 
refractoriness.
Electroanatomical mapping showed larger vol-
umes, lower mean bipolar voltage, a slower mean 
conduction velocity, and a prolonged total atrial 
activation time in the AF group as compared to the 
reference group. Evaluation of complex electro-
grams showed significantly greater proportion of 
points with double potentials or fractionated sig-
nal in the AF group than the reference group (27 ± 
8% vs. 8 ± 5%, p<0.001).
Since the early models of AF, it has been shown 
that the arrhythmia itself causes electrophysi-
ological changes in the atrial substrate, including 
a shortening and heterogeneity of the atrial refrac-
tory period, and prolongation of the sinus node re-
covery time, which can lead to further AF .8-10 These 
studies yielded the conclusion that “AF begets AF, 
10” however, aggressive attempts at cardioversion 
or antiarrhythmic drugs to maintain sinus rhythm 
may slow but has failed to prevent the progression 
of this disease. 11 Therefore, authors suggested that 
“sinus rhythm does not beget sinus rhythm” in 
lone AF. Mechanistically AF is thought to be due 
to the interaction between a trigger and atrial sub-
strate. In 1972, Zipes et al. demonstrated electrical 
activity within the thoracic veins .12 Twenty seven 
years later, Haissaguerre et al. identified a focal 
source of electrical discharges within the pulmo-
nary veins as a source of AF 13 and opened the door 
to a new potential treatment modality and new 
mechanisms of AF. However, treatment of triggers 
has not been successful in all patients with parox-
ysmal or lone AF. On the contrary, substrate
modification along with the treatment of triggers 
of persistent and permanent AF has been effective, 
at least, in few patents. Several studies try to in-
vestigate the substrates and associated risk factors 
involved the pathogenesis of paroxysmal AF. A 
familial predisposition for AF has been frequently
seen clinically. Mutations in potassium chan-
nels, sodium channels as well as connexins have 
been implicated in rare forms of monogenic AF, 
although no more common genetic link has been 
found. 14,15 Multiple other risk factors such as obe-
sity and weight gain, obstructive sleep apnea, in-
flammation, excessive endurance exercise, and 
toxins ranging from alcohol to caffeine have been 
shown to be associated with AF. Lone AF patients 
do not have any known risk factor for AF, yet sinus 
rhythm does not beget sinus rhythm in them. Of 
the electrophysiological findings of this study the 
one that stands out is a prolongation of the atrial 
ERP in patients with AF. Heretofore, evaluations 
of the ERP have been performed in the acute pe-
riod, soon after conversion of AF, and have dem-
onstrated a shortening of the ERP. However, it 
is unclear in the study what the burden of recip-
rocating tachycardia the reference group had, 
and whether it may have abnormally shortened 
the refractory period in the reference group. It 
could be that, although the arrhythmogenicity of 
a shortened atrial ERP after conversion to sinus
is the cause of acute recurrence of AF, a pro-
longed ERP and CV characterizes the underly-
ing arrhythmogenic substrate in initiation and 
maintenance of AF. This was a small and select 
subgroup of patients with highly symptomatic 
AF and no cardiac risk factors or structural heart 
disease, on the other hand, so caution must be 
maintained when generalizing to the AF popula-
tion as a whole.
2.Abnormal Sinus Node Function
The study evaluated the baseline sinus cycle 
length,sinoatrial conduction time (SACT), and 
corrected sinus node recovery time (CSNRT). 
Patients with AF have an impaired sinus node 
function (the corrected sinus node recovery time 
was prolonged by 43%). AF patients had a longer 
baseline sinus cycle length (975 ± 131ms, vs. 762 
± 129 ms, p<0.001), longer SACT (154 ± 58 ms vs. 
83 ± 31ms, p<0.001), and longer CSNRT at 600 ms 
(265 ± 57ms vs. 185 ± 60 ms, p = 0.002), but not at 
450 ms (261 ± 96 ms vs. 241 ± 76 ms, 9=0.6). These 
findings confirm an abnormal sinus node func-
tion in lone AF, although it cannot be defined as 
a clinically significant sinus node dysfunction 
(SND). With the progression of the disease to 
persistent AF, sinus node function can worsen. 
SND is an abnormality involving the generation 
of the action potential by the SAN and is charac-
terized by an atrial rate inappropriate for physi-
ological requirements. SND occurs in 1 in every 
600 patients with heart disease above 65 years of 
age and accounts for approximately half of im-
plantations of pacemakers in the United States. 
Several intrinsic or extrinsic factors may influ-
ence sinus node function, although age-depen-
dent primary degenerative fibrosis of the tissues 
of the sinus node is thought to be the primary 
cause of SND. 16 Manifestations of SND include 
symptomatic sinus bradycardia, sinus pauses, 
sinus node exit block, sinus arrest and chrono-
tropic incompetence. 17 A subset of patients with 
AF suffer from sinus node dysfunction (SND), 
which is defined as tachy-brady syndrome. 18-22 
The tachy-brady syndrome is a common manifes-
tation of SND and is the combination of abnormal 
automaticity (bradycardia) and abnormal conduc-
tion properties of the atrium which predispose 
patients to AF and other atrial arrhythmias. Con-
versely, proportion of patients with SND who re-
ceive a pacemaker suffer from AF during follow-
up .23This study, like others, has demonstrated that 
AF is associated with significant electrophysiologi-
cal and structural remodeling 24 Furthermore, SND 
encountered in patients with paroxysmal or per-
sistent AF, can reverse with catheter ablation of AF 
[18]. It is possible that SND and AF are interrelated 
and may be the two spectrums of the same disease 
or at least share some common mechanisms, with 
clinical symptoms that depend upon severity of 
these two arrhythmias.
The main limitation of the study is that patients 
with persistent AF were not studied; however, 
many patients with persistent AF start with parox-
ysmal AF initially and possibly the same “second
factors” continue to work in this stage of the dis-
ease. Furthermore, patients were monitored only 
for a week before the procedure to ensure that the 
evaluation was remote from an episode of AF; nev-
ertheless, an effect of rate-related remodeling from 
previous episodes cannot be excluded.
The study by Stiles et al, has shown that lone AF is 
associated with structural and electrophysiological
remodeling of atria and the SAN. Whether “sec-
ond factors,” are the result of progressive fibrosis,
inflammation, or any of a number of other mecha-
nism is still remains to be elucidated. The authors, 
by studying patients remote in time from the ar-
rhythmia itself, have been able to show that the 
predominant underlying substrate in patients with 
lone AF is structural and electrophysiological re-
modeling, perhaps accounting for the progression
of the disease. Future strategies to treat paroxys-
mal or lone AF should, therefore, also focus on 
atrial substrate. It may be valuable since pulmo-
nary vein isolation is currently considered to be 
only moderately successful (success rate 70-85%) 
for the majority of patients with paroxysmal AF. It 
is often difficult to predict which patient will have 
a recurrence of the arrhythmia after catheter abla-
tion. This study showing an abnormal substrate in
lone AF raises the possibility of progressive disease
continuing despite early procedural success. Fur-
ther study is needed to define the role of substrate 
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in recurrence of paroxysmal AF despite achieving 
a good pulmonary vein isolation and substrate 
modification. A combination of detailed noninva-
sive evaluation of atrial dimensions and function 
with echocardiography and/or enhanced magnetic 
resonance imaging techniques along with a high 
density mapping of the electrophysiological sub-
strate (fractionated electrograms, dominant fre-
quencies, CV, ERP, etc) as well as triggers (pulmo-
nary vein and non-pulmonary vein sources) may 
be needed to improve the long-term success rate 
of AF ablation. The study provides an encourage-
ment to find a “cure” for AF by identifying “sec-
ond factors” and its role in disease progression.
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